Market Insights Health Medical Technology Medical Devices

Diabetes Care Devices - Southern Asia

Southern Asia

In Southern Asia, revenue in the Diabetes Care Devices market market is projected to reach US$1.24bn in 2024.
The revenue is anticipated to exhibit an annual growth rate (CAGR 2024-2029) of 13.45%, leading to a market volume of US$2.33bn by 2029.
In a global context, the majority of revenue will be generated the United States, with a forecast of US$11,710.00m in 2024.
In Southern Asia, particularly India, there is a growing emphasis on innovative diabetes care devices driven by rising prevalence and increasing healthcare awareness among patients.

Key regions: Netherlands, Japan, France, Italy, China

Market

Region

Region comparison

Currency

Analyst Opinion

The Diabetes Care Devices Market in Southern Asia is witnessing considerable growth, fueled by increasing diabetes prevalence, rising health awareness, and advancements in technology that enhance patient management and monitoring for improved health outcomes.

Customer preferences: Consumers in Southern Asia are increasingly prioritizing personalized diabetes management solutions, reflecting a shift towards devices that cater to individual health needs and preferences. This trend is influenced by a growing awareness of diabetes-related complications and the importance of proactive management. Additionally, younger demographics are embracing technology, leading to a rise in demand for smart glucose monitoring devices and mobile health applications. Cultural factors, such as family involvement in health decisions, further drive the demand for user-friendly devices that facilitate collaborative care.

Trends in the market: In Southern Asia, the Diabetes Care Devices Market is experiencing a notable shift towards integrated digital health solutions, with an increasing adoption of continuous glucose monitoring systems and insulin delivery devices that offer real-time data to users. The rise of mobile health applications is empowering patients to manage their diabetes better, fostering a proactive approach to health. This trend is significant as it not only enhances patient engagement but also encourages adherence to treatment plans. Industry stakeholders, including device manufacturers and healthcare providers, must adapt to these evolving preferences, focusing on user-friendly innovations to support personalized care and improve patient outcomes.

Local special circumstances: In Southern Asia, the Diabetes Care Devices Market is shaped by diverse factors such as rising urbanization, dietary changes, and a high prevalence of diabetes. Cultural attitudes towards health management vary significantly, with traditional beliefs influencing treatment adherence. Regulatory landscapes are evolving, with governments increasingly prioritizing diabetes care through favorable policies and subsidies. Additionally, the limited access to healthcare in rural areas drives demand for affordable, user-friendly devices, enabling patients to manage their conditions effectively despite geographical barriers.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Southern Asia is significantly influenced by macroeconomic factors such as rising disposable incomes, urbanization, and increasing healthcare expenditures. National economic health plays a crucial role, as countries with robust economic growth are more likely to invest in healthcare infrastructure and diabetes management initiatives. Additionally, fiscal policies promoting health awareness and preventive care are enhancing market potential. Global economic trends, including the expansion of telemedicine and digital health technologies, are also shaping the landscape, providing innovative solutions that cater to the unique needs of diabetic patients across the region.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.